Switching from blonanserin tablets to blonanserin transdermal patches improves tardive dyskinesia: A case report
Abstract Tardive dyskinesia (TD) is a common side effect of antipsychotics, and it remains a persistent and challenging problem. The blonanserin transdermal patch, developed in Japan and launched in September 2019, is the first antipsychotic transdermal treatment. Here, we describe a patient with sc...
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Wiley
2021-09-01
|
| Edice: | Neuropsychopharmacology Reports |
| Témata: | |
| On-line přístup: | https://doi.org/10.1002/npr2.12200 |